How does the angiotensin II type 1 receptor 'trump' the type 2 receptor in blood pressure control?

Journal of Hypertension

Volumn 31, Issue 4, 2013, Pages 705-712

  Schalekamp, Maarten A D H ^a   Danser, A H Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

angiotensin II; Arteriole; AT1 receptor; AT2 receptor; Vasoconstriction; Vasodilation

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR;

ARTICLE; BINDING AFFINITY; BLOOD PRESSURE REGULATION; CAPILLARY FLOW; CELL SURFACE; DIFFUSION; ENDOTHELIUM; HUMAN; INTERSTITIUM; NONHUMAN; PRIORITY JOURNAL; THICKNESS; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 84875216840     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835d6d11     Document Type: Article

References (28)

1. Schalekamp MADH, Danser AHJ. Facilitated diffusion of angiotensin II from perivascular interstitium to AT1 receptors of the arteriole. A regulating step in vasoconstriction. J Hypertens 2011; 29:906- 914.
2. Fierens F, Vanderheyden PM, De Backer JP, Vauquelin G. Binding of the antagonist [3H]candesartan to angiotensin II AT1 receptortransfected Chinese hamster ovary cells. Eur J Pharmacol 1999; 367:413-422.
3. Schalekamp MADH. A local prereceptor mechanism of hormone stimulus amplification: focus on angiotensin II in resistance blood vessels. J Hypertens 2006; 24:1787-1796.
4. Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 2008; 120:292-316.
5. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995; 95:46-54.
6. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95:651- 657.
7. Henrion D. Why do we need a selective angiotensin II type 2 receptor agonist? Hypertension 2012; 60:616-617.
8. Verdonk K, Durik M, Abd-Alla N, Batenburg WW, van den Bogaerdt AJ, van Veghel R, et al. Compound 21 induces vasorelaxation via an endothelium- and angiotensin II type 2 receptor-independent mechanism. Hypertension 2012; 60:722-729.
9. Hein L, Meinel L, Pratt RE, Dzau VJ, Kobilka BK. Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol 1997; 11:1266- 1277.
10. Dell'Italia LJ, Meng QC, Balcells E, Wei CC, Palmer R, Hageman GR, et al. Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest 1997; 100:253-258.
11. Siragy HM, Howell NL, Ragsdale NV, Carey RM. Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension 1995; 25: 1021-1024.
12. Schuijt MP, van Kats JP, de Zeeuw S, Duncker DJ, Verdouw PD, Schalekamp MADH, Danser AHJ. Cardiac interstitial fluid levels of angiotensin I and II in the pig. J Hypertens 1999; 17:1885-1891.
13. Schuijt MP, de Vries R, Saxena PR, Schalekamp MADH, Danser AHJ. Vasoconstriction is determined by interstitial rather than circulating angiotensin II. Br J Pharmacol 2002; 135:275-283.
14. Schalekamp MADH, Danser AHJ. Angiotensin II production and distribution in the kidney: I. A kinetic model. Kidney Int 2006; 69:1543-1552.
15. Schalekamp MADH, Danser AHJ. Angiotensin II production and distribution in the kidney: II. Model-based analysis of experimental data. Kidney Int 2006; 69:1553-1557.
16. van Kats JP, Chai W, Duncker DJ, Schalekamp MADH, Danser AHJ. Adrenal angiotensin. Origin and site of generation. Am J Hypertens 2005; 18:1045-1051.
17. van Kats JP, Danser AHJ, van Meegen JR, Sassen LM, Verdouw PD, Schalekamp MADH. Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation 1998; 98:73-81.
18. van Kats JP, Schalekamp MADH, Verdouw PD, Duncker DJ, Danser AHJ. Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int 2001; 60:2311-2317.
19. van Esch JHM, Gembardt F, Sterner-Kock A, Heringer-Walther S, Le T, Lassner D, et al. Cardiac phenotype and angiotensin II levels in AT1a, AT1b and AT2 receptor single, double and triple knockouts. Cardiovasc Res 2010; 86:401-409.
20. Kenakin T. Diffusion and drug concentration in receptor compartments. In Pharmacological analysis of drug-receptor interaction. Philadelphia, USA: Lippincott-Raven Publishers; 1997. pp. 145- 197.
21. Bosnyak S, Welungoda IK, Hallberg A, Alterman M, Widdop RE, Jones ES. Stimulation of angiotensin AT2 receptors by the nonpeptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br J Pharmacol 2010; 159:709- 716.
22. van Esch JHM, Schuijt MP, Sayed J, Choudry Y, Walther T, Danser AHJ. AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation. Br J Pharmacol 2006; 148:452- 458.
23. You D, Loufrani L, Baron C, Levy BI, Widdop RE, Henrion D. High blood pressure reduction reverses angiotensin II type 2 receptormediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation 2005; 111:1006-1011.
24. Moltzer E, Verkuil AV, van Veghel R, Danser AHJ, van Esch JHM. Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptor-mediated vasodilation. Hypertension 2010; 55:516- 522.
25. Bautista R, Sanchez A, Hernandez J, Oyekan A, Escalante B. Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure. Hypertension 2001; 38:669-673.
26. Savoia C, Tabet F, Yao G, Schiffrin EL, Touyz RM. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. J Hypertens 2005; 23:1037-1045.
27. Savoia C, Touyz RM, Volpe M, Schiffrin EL. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension 2007; 49:341-346.
28. AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 2001; 276:39721-39726.